The role of radionuclide imaging in heart failure

J Nucl Cardiol. 2013 Dec;20(6):1173-83. doi: 10.1007/s12350-013-9776-1.

Abstract

The incidence of heart failure (HF) is increasing and it remains the only area in cardiovascular disease wherein hospitalization rates and mortalities have worsened in the past 25 years. This review is provided to assess the role of radionuclide imaging in HF. The focus is on three aspects: the value of nuclear imaging to distinguish ischemic from non-ischemic etiologies; risk stratification of patients with HF with evaluation of candidates for specific treatment strategies; and the role of cardiac neuronal imaging in patients with HF. Distinguishing ischemic from non-ischemic cardiomyopathy is important because patients with ischemic cardiomyopathy can potentially have dramatic improvement with revascularization. Single photon emission computed tomography (SPECT) has excellent reported sensitivity and negative predictive value in the detection of coronary artery disease in HF patients. SPECT imaging is also useful in establishing treatment strategies in patients with HF, including those with new onset CHF. Cardiac neuronal imaging of mIBG is particularly helpful in risk stratification of patients with HF. The modality can be used to monitor the response to therapy as dysfunctional mIBG uptake may show improvement with pharmacological treatment.

Publication types

  • Review

MeSH terms

  • Heart Failure / diagnostic imaging*
  • Humans
  • Myocardial Ischemia / diagnostic imaging
  • Myocardial Perfusion Imaging
  • Positron-Emission Tomography
  • Tomography, Emission-Computed, Single-Photon
  • Ventricular Function, Left